HEALTH RISKS ASSOCIATED WITH DIET PILL ABUSE
HEALTH RISKS ASSOCIATED WITH DIET PILL ABUSE
There are health concerns associated with the overuse or abuse of any drug. Abuse can occur with any over-the-counter or prescription drug, including weight loss products. Some of those health concerns are discussed here.
Laxatives and Diuretics
Many people abuse laxatives and diuretics in [...]
Diet Drug Acomplia Sales Disappoint; No Major Improvement Seen Until 2009
Sales of diet drug Acomplia (rimonabant) , available in Europe but not approved in the U.S., have turned into a major disappointment for Sanofi-Aventis, which says it does not expect the situation to significantly improve until new clinical trial results are ready for submission to regulators in [...]
Sanofi to Present More Acomplia Data at April 11th Meeting
Sanofi-Aventis, developer of the highly publicized anti–obesity drug Acomplia, will present new data on the drug’s role in reducing metabolic cardiovascular disease risk factors at a scientific meeting in San Diego April 11th and 12th.
Dr. Pierre Rosenzweig, a Vice President of Sanofi-Aventis, will make the presentation at the Annual Metabolic [...]
Report in The Lancet Further Boosts Interest in Weight-Loss Drug Acomplia
A report published in this week’s issue of the prestigious medical journal, The Lancet, further stoked interest in the promising new weight-loss drug Acomplia (rimonabant) but in fact provided little new information.
The report was based on one-year results from the RIO–Europe clinical trial, which showed [...]
FDA Advisory Panel Says Obese Kids Should Be Included in Drug Trials
A U.S. FDA Advisory Committee reviewing guidelines for weight-loss drug trials appear prepared to call for studies that focus on the effect of anti–obesity drugs on severely obese children Acomplia (rimonabant) .
Acomplia (rimonabant) “This population of patients needs to be studied separately from the [...]
AMPHETAMINE-LIKE WEIGHT LOSS PRODUCTS
AMPHETAMINE-LIKE WEIGHT LOSS PRODUCTS
Amphetamines, which were introduced in 1938, rapidly became the most widely used agents for the treatment of obesity in the United States. Amphetamine (Figure ) is a stimulant that causes the release of the neurotransmitter norepinephrinein the brain, which leads to increased metabolism and increased energy expenditure, or burning of [...]
Experimental Obesity Drug APD356 Reported Effective in Small, Short Trial
A year ago at this time, millions of overweight and obese An experimental drug for the treatment of obesity, APD356, reportedly produced encouraging results in a relatively small four week clinical trial, according to a statement released by Arena Pharmaceuticals, Inc Acomplia (rimonabant) .
Arena said [...]
New Acomplia News Will Be Presented on March 8th
After a four-month dry spell during which there has been little news about development of the highly publicized obesity drug Acomplia (rimonabant) , researchers are scheduled to present new data from the RIO–Europe clinical trial at a scientific meeting in Orlando on Tuesday, March 8th.
The presentation of the [...]
